Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland.

Boyter AC, Steinke DT.

Pharmacoepidemiol Drug Saf. 2005 Mar;14(3):203-9.

PMID:
15624197
2.

Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Vogelmeier C, Naya I, Ekelund J.

Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.

PMID:
22607479
5.

Differential prescribing of inhaled corticosteroids in New Zealand general practice.

Hall J, Penrose A, Tomlin A, Reid J.

N Z Med J. 2003 Aug 22;116(1180):U563.

PMID:
14581985
6.

Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand.

Black PN, Lawrence BJ, Goh KH, Barry MS.

Eur J Clin Pharmacol. 2000 Aug;56(5):431-5.

PMID:
11009054
7.

Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.

O'Byrne PM, Rennard S, Gerstein H, Radner F, Peterson S, Lindberg B, Carlsson LG, Sin DD.

Respir Med. 2012 Nov;106(11):1487-93. doi: 10.1016/j.rmed.2012.07.011. Epub 2012 Aug 15. Review.

8.

The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.

Cave AC, Hurst MM.

Pharmacol Ther. 2011 May;130(2):114-43. doi: 10.1016/j.pharmthera.2010.12.008. Epub 2011 Jan 27. Review.

PMID:
21276815
9.

Trends in use of inhaled corticosteroids for asthma management: 1994-1998.

Allen-Ramey FC, Samet JM, Rand CS, Joseph CL.

Ann Epidemiol. 2004 Mar;14(3):161-7.

PMID:
15036218
10.

Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).

[No authors listed]

Med Lett Drugs Ther. 2010 May 31;52(1339):41-2. No abstract available.

PMID:
20508579
11.
12.

Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand.

Johansson M, Hall J, Reith D, Jackson P, Tilyard M.

Eur J Clin Pharmacol. 2003 Sep;59(5-6):483-7. Epub 2003 Aug 23.

PMID:
12937871
15.

Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.

Donohue JF, Ohar JA.

Proc Am Thorac Soc. 2004;1(3):152-60. Review.

PMID:
16113428
16.

Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.

Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.

Br J Clin Pharmacol. 2003 Nov;56(5):494-500.

17.

Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period.

Krigsman K, Moen J, Nilsson JL, Ring L.

J Clin Pharm Ther. 2007 Dec;32(6):603-11.

PMID:
18021338
18.
19.

An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.

McGowan B, Bennett K, Barry M, Owens M, O'Connor M.

Ir Med J. 2009 Mar;102(3):73-6.

PMID:
19489193
20.

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.

Aballéa S, Cure S, Vogelmeier C, Wirén A.

Int J Clin Pract. 2008 Dec;62(12):1870-9. doi: 10.1111/j.1742-1241.2008.01895.x. Epub 2008 Sep 17.

Supplemental Content

Support Center